Article citationsMore>>

Nakamura, K., Yoshikawa, N., Yamaguchi, Y., Kagota, S., Shinozuka, K. and Kunitomo, M. (2006) Antitumor effect of cordycepin(3’-deoxyadenosine)on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Research, 26, 43-47.

has been cited by the following article:

• TITLE: Certainty of patient survival with reference to game information dynamic model

  AUTHORS: Hiroyuki Iida, Takeo Nakagawa, Nathan Nossal

  KEYWORDS: Certainty of Patient Survival; Game Information Dynamic Model; Naturopathic Therapy; Herbal Treatment; Natural Antioxidants; Hepato-Cellular Carcinoma

  JOURNAL NAME: Open Journal of Preventive Medicine, Vol.2 No.4, November 29, 2012

  ABSTRACT: This paper is concerned with Hepato-Cellular Carcinoma (HCC) patients treated naturopathic agents. Patients treated with ≥4 agents survived significantly longer than patients treated with ≤3 agents. The great effect is seen in patients treated with at least 4 agents that include Cordyceps sinensis. This greater certainty of patient survival without toxic side effects is significant benefit comparing with the conventional therapy. Treatment of HCC with a regimen of ≥4 agents prepared from natural products is associated with greater certainty of patient survival in a substantial portion of patients. The information dynamic model for certainty of patient survival is derived based on fluid mechanics, where a series of approximate solutions of the flow between two parallel flat walls, one of which is at rest, the other is suddenly accelerated from the rest to a constant velocity are used. The kinetic energy of certainty of patient survival decreases with increasing time, while the potential energy increases with increasing time. Total mechanical energy of patients treated with 4 or more agents is smaller than that treated with 3 or fewer agents. The kinetic energy (potential energy) of patients treated with 4 or more agents decreases (increases) more slower than the kinetic energy (potential energy) of patients treated with 3 or fewer agents.